Listen to The Lancet Gastroenterology & Hepatology

Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.

Prof Raymond Chung discusses new research in transplantation of HCV-infected hearts.

Daniel Lambrichts joins  The Lancet Gastroenterology & Hepatology to discuss different treatments for diverticulitis.

Dr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS.

Dr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition.

Philippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents.

Stuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers.

Dr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome.

Bart Rijnders discusses his recent work on the treatment of people with acute hepatitis C.

Jennifer Flemming talks with  The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease.

Graham Foster speaks with  The Lancet Gastroenterology & Hepatology about his recent work on incentivising and supporting primary-care physicians to increase hepatitis screenings of migrant populations.

Behzad Hajarizadeh joins  The Lancet Gastroenterology and Hepatology to discuss his work with direct-acting antiviral treatments for hepatitis C among people inject drugs.

Michele Reni speaks with  The Lancet Gastroenterology & Hepatology about the PAXG regimen for treatment of pancreatic cancer.

Marco Carbone talks to  The Lancet Gastroenterology & Hepatology  about predicting treatment response for patients with primary biliary cholangitis

Homie Razavi and Devin Razavi-Shearer join The Lancet Gastroenterology & Hepatology to discuss their HBV modelling study.

Jasper Vleugels joins The Lancet Gastroenterology and Hepatology to discuss the results of the FIND-UC trial.

Imran Aziz discusses his paper on functional dyspepsia, which is published in the April issue of The Lancet Gastroenterology & Hepatology .

In this  Lancet Gastroenterology & Hepatology podcast, Johannes Vermehren discusses the risks of Hepatitis B reactivation in coinfected patients receiving treatment for Hepatitis C.

Sandra Andorf and Kari Nadeau discuss their work on anti-IgE treatment with oral immunotherapy in multifood allergic participants.

Peter Johnsen discusses his paper on faecal transplantation as a treatment for IBS.

Jeffrey Hyams discusses the PROTECT study, which looks at outcomes in paediatric ulcerative colitis.

Yeng Ang and James Britton discuss setting research priorities for future work in Barrett's oesophagus and gastro-oesophageal reflux disease

Adrian Miranda talks about his work on using neurostimulation as a method for addressing abdominal pain-related functional gastrointestinal disorders in children.

Mark Fox talks about development of a solid meal test for diagnosing oesophageal motility disorders.

Federico Aucejo talks about his HALT-HCC score, which assesses risk for patients with hepatocellular carcinoma awaiting liver transplant.